Clinical Trials · NCT03860688
Effects of Oral Glucose and Teduglutide on Plasma Lipoproteins
- Phase
- Phase 2/Phase 3
- Recruitment status
- Unknown
- Sponsor
- University Health Network, Toronto
- Enrollment
- 15
- Start date
- May 2019
- Locations
- 1 site, Canada
- Primary endpoint
- Lipoprotein response to teduglutide and glucose